Senate confirms Hahn as FDA commissioner
The Senate today voted 72-18 to confirm Stephen Hahn, M.D., as Food and Drug Administration commissioner. Hahn currently serves as chief medical executive and professor of radiation oncology at The University of Texas MD Anderson Cancer Center in Houston. He previously chaired the Department of Radiation Oncology at the University of Pennsylvania and before that was a senior investigator at the National Cancer Institute.
Commenting on the nomination Nov. 1, AHA President and CEO Rick Pollack said Hahn’s “more than 20 years of experience on the front lines of delivering patient care, overseeing clinical research and operations, and quality and safety initiatives makes him a uniquely qualified nominee to lead the FDA.”
Related News Articles
Headline
The Senate March 25 confirmed Marty Makary as the new commissioner of the Food and Drug Administration and Jay Bhattacharya as the new director of the National…
Headline
Tom Engels is the new administrator for the Health Resources and Services Administration, according to its website. Engels previously held the same position in…
Headline
Health and Human Services Secretary Xavier Becerra Jan. 8 appointed as chief competition officer Stacy Sanders, who currently oversees the department's…
Headline
President Biden intends to appoint as the next Centers for Disease Control and Prevention director Mandy Cohen, M.D., who served as secretary of the North…
Headline
The Government Accountability Office May 26 announced the appointment of five new members to the Medicare Payment Advisory Commission, along with two…
News
The AHA today sent letters to leaders of the Senate Committee on Health, Education, Labor and Pensions and the Senate Committee on Finance expressing the…